These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35001356)

  • 1. MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.
    Khezri MR; Yousefi K; Zolbanin NM; Ghasemnejad-Berenji M
    Mol Neurobiol; 2022 Mar; 59(3):1589-1603. PubMed ID: 35001356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
    Zhang J; Chen Z; Chen H; Deng Y; Li S; Jin L
    Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
    Sivagurunathan N; Ambatt ATS; Calivarathan L
    Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.
    Tripathi R; Kumar P
    Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37635325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
    Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
    Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
    Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and Its Altered Action in Alzheimer's Disease and Parkinson's Disease.
    Duc Nguyen H; Pal Yu B; Hoang NHM; Jo WH; Young Chung H; Kim MS
    Neuroendocrinology; 2022; 112(5):427-445. PubMed ID: 34126620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Olfactory Trail of Neurodegenerative Diseases.
    Franco R; Garrigós C; Lillo J
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.
    Rezaee D; Saadatpour F; Akbari N; Zoghi A; Najafi S; Beyranvand P; Zamani-Rarani F; Rashidi MA; Bagheri-Mohammadi S; Bakhtiari M
    Ageing Res Rev; 2023 Dec; 92():102090. PubMed ID: 37832609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.
    Van der Schyf CJ
    Drug Dev Res; 2016 Dec; 77(8):458-468. PubMed ID: 27813127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
    Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
    Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
    Bisht I; Ambasta RK; Kumar P
    Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in lentiviral vector-mediated gene therapy for Alzheimer's disease and Parkinson's disease].
    Xu D; Liu L; Lang M
    Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2707-2718. PubMed ID: 33398966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Going around in circles: deciphering the role of circular RNAs in neurodegenerative disease.
    Kondo MA; Mohan A; Mather KA
    Curr Opin Psychiatry; 2020 Mar; 33(2):141-147. PubMed ID: 31895158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.